Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CCNQ pseudogene 3 is annotated as a pseudogene locus in the human genome. Pseudogenes are generally non-protein-coding genetic elements that resemble known genes but contain sequence disablements such as premature stop codons or frameshifts[4]. While traditionally considered non-functional, recent studies reveal that some pseudogenes can play regulatory roles by acting as competitive endogenous RNAs (ceRNAs), modulating gene expression through microRNA decoy activity[1][2][5]. However, there is no direct evidence that CCNQ pseudogene 3 encodes any functional RNA or modulates biological pathways or disease processes. It is not considered a receptor, enzyme, transporter, or pharmacological target[3]. CCNQP3 has no reported disease associations, interacting drugs, or biomarker status. This entry is considered incorrect as a druggable target: while pseudogenes can have regulatory function via ceRNA networks, CCNQP3 itself is not an established functional pseudogene, nor is it therapeutically actionable[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CCNQ pseudogene 3 (CCNQP3).